Skip to content

GUY.01 Reducing the burden of disease: communicabl

Guyana's modes of transmission study experience

Print E-mail


UNAIDS’ advocacy for countries to “Know Your Epidemic and Know your Response” is based on the
premise of advanced data collection, analysis and use. For this reason, the UNAIDS Reference Group for Estimations, Models and Projections developed the Modes of Transmission (MOT) model in 2002. It’s meant to help countries estimate the distribution of new HIV infections by modes of transmission and use existing epidemiological data to better target prevention programming.

Guyana is a small country with notable resource constraints. Considerable efforts have been made to mitigate the effects of HIV on its relatively small population. In this context it is especially important to ensure that the optimal use of data leads to the most effective use of resources.

Because Guyana has been one of the most heavily affected countries in the region, its HIV and AIDS response has also benefited from both financial and technical support from multiple sources (Global Fund, United States Government, the Canadian International Development Agency (CIDA) and United Nations agencies).

Last Updated on Thursday, 06 September 2012 11:37

Infection Control Mission to Guyana 1-7 July 2012

Print E-mail


Ministry of Health in collaboration with the Pan American Health Organization/World Health Organization (PAHO/WHO) conducted a seven-day mission in Guyana from 1 to 7 July 2012.  
The objectives were to:

1) Finalize the National Infection Control Strategic Plan 2012-2016
2) Update the Infection Prevention and Control Manual for hospital level; and
3) Identified the generic guidelines for the establishment of the Infection Control Committees at hospital level.

Eighteen (18) participants attended the Infection Control Stakeholder Meeting held at Herdmanston Lodge. The participants were representative from:

•    MOH Regional Health Authorities and Infection Control Focal Points from Regions 2, 4, 6 and 10; MOH Central Level - Chief Medical Officer (CMO), Permanent Secretary (PS), National Tuberculosis Program (NTP), Information Technology (IT) Unit, Surveillance Unit and Director Standards and Technical Services
•    Prison Services Authorities
•    Centre for Disease Control and Prevention
•    PAHO/WHO   


Last Updated on Thursday, 02 August 2012 15:41

Implementation of basic quality control tests for malaria medicines in Amazon Basin countries: results for the 2005-2010 period

Print E-mail



Ensuring the quality of malaria medicines is crucial in working toward malaria control andeventual elimination. Unlike other validated tests that can assess all critical quality attributes,which is the standard for determining the quality of medicines, basic tests are significantlyless expensive, faster, and require less skilled labour; yet, these tests provide reproducibledata and information on several critical quality attributes, such as identity, purity, content,and disintegration. Visual and physical inspection also provides valuable information aboutthe manufacturing and the labelling of medicines, and in many cases this inspection is sufficient to detect counterfeit medicines. The Promoting the Quality of Medicines (PQM) programme has provided technical assistance to Amazon Malaria Initiative (AMI) countries to implement the use of basic tests as a key screening mechanism to assess the quality of malaria medicines available to patients in decentralized regions.  

icon Implementation of basic quality control tests for malaria medicines in Amazon (693.89 kB)

Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname

Print E-mail



Despite a significant reduction in the number of malaria cases in Guyana and Suriname, this disease remains a major problem in the interior of both countries, especially in areas with gold mining and logging operations, where malaria is endemic. National malaria control programmes in these countries provide treatment to patients with medicines that are procured and distributed through regulated processes in the public sector. However, availability to medicines in licensed facilities (private sector) and unlicensed facilities (informal sector) is common, posing the risk of access to and use of non-recommended treatments and/or poor quality products.

icon Quality of anti-malarials collected in the private and informal sectors in Guyana and Suriname (257.1 kB)


Last Updated on Wednesday, 11 July 2012 09:17

Strengthening Laboratory Capacity for Diagnosis and Management of Chagas Disease for Primary HealthCare Workshop

Print E-mail

 The Ministry of Health in collaboration with the Pan American Health Organization/World Health Organization (PAHO/WHO) conducted a three-day training for primary health care personnel on strengthening laboratory capacity for diagnosis and management of Chagas disease. Twenty-eight (28) persons participated in the training, which was held from 26 to 28 June 2012 at the National Reference Laboratory, Georgetown. Clinicians participated in the first day of the training and laboratory technicians participated the following two days.

The three-day workshop was facilitated by Dr. Alejandro Luquetti, Professor, University of Brazil.

Dr. Shamdeo Persaud, Chief Medical Officer, Ministry of Health, in his opening remarks welcomed the participants and highlighted the importance of the training.  He stated that the focus is to create awareness of the Chagas disease, and to explore diagnosis criteria and management and treatment of the disease. He further mentioned that in Guyana, evidence gathered from blood bank screening and small studies done indicates there are positive cases of Chagas disease.

Dr. Nicolas Ceron, PAHO/WHO Specialist, Malaria Prevention and Control, stated that with the increase in international travel and open borders, especially in South and Central America, the disease is now globally distributed. The prevalence of Chagas disease in the Amazon is estimated at about 3% with 10-14 million cases. Incidence is estimated at about 1.5 million annually, due to increased access to habitat of the vector of transmission.  He further stated that efforts to interrupt the transmission of Chagas disease have been successful in several countries and must continue through vector control and blood bank screening. Transmission by blood transfusion has increasingly been reported as the cause of new infections outside the foci natural transmission.

Dr. Ceron advised that all of these strategies are in the local Neglected Tropical Diseases (NTD) plan and that training was important in order to continue the implementation of the Chagas plan in Guyana.

Last Updated on Wednesday, 11 July 2012 09:23
<< Start < Prev 1 2 3 4 5 6 7 Next > End >>

Page 4 of 7

Lot 8 Brickdam Stabroek, Georgetown, Guyana, P.O. Box 10969 ,Georgetown, Guyana
Tel.: +592 225-3000; +592 227-5150; +592 227-5158; +592 227-5159;+592 227-6371; +592 223-6372
Fax: +592 226-6654; +592 227-4205 email